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Functional recoveryAbstract Aim: To clarify the value of dobutamine stress tissue Doppler in the evaluation of LV
functional improvement after elective PCI.
Methods: The study included 60 patients with hibernating viable myocardium proved by DSE
referred for an evaluation of myocardial viability prior to revascularization. Hemodynamic and
echocardiographic variables (LVEF, WMSI and TDI Sm) were assessed at rest and during stress.
1 month after PCI follow up echocardiography and TDI were done. Patients were divided into 2
groups: (Group I): 18 patients (30%) with no global functional recovery and (Group II): 42 patients
(70%) with global functional recovery.
Results: SBP, DPB, HR, EF, WMSI and (Sm) increased signiﬁcantly at stress P= 0.001. After
1 month patients were divided into 2 groups according to functional recovery. There were no
statistically signiﬁcant differences between two groups neither as regards age, sex, risk factors
(P> 0.05) nor as regards SBP, DBP, HR, rate/pressure product, EF and WMSI during stress
but Sm increased during stress and after1 month follow up in Group II (P= 0.001). Univariate
regression showed that (Sm) is the only predictor for global functional recovery. ROC curve
statistical analysis shows that (Sm) is more sensitive and accurate than (WMSI) in the detection
of viable myocardium which predicts improvement after revascularization (sensitivity 100%,
50% and accuracy 93.3%, 83.3% respectively).; DSE,
F, left
systolic
262 S.A. Mostafa et al.Conclusion: Stress TDI provides a feasible and quantitative technique that improves reproducibil-
ity of DSE. Sm during stress showed better accuracy than WMSI for the prediction of functional
recovery following revascularization and was simple, sensitive and accurate for the detection of sub-
tle myocardial systolic velocity changes.
ª 2014 The Authors. Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/3.0/).1. Introduction
Coronary artery disease (CAD) remains a principal cause of
morbidity and mortality worldwide. Many subjects with coro-
nary artery disease have viable but dysfunctional myocardium,
where a kinetic or severely hypokinetic myocardium keeps the
ability to contract if perfusion improves.1
Dobutamine stress echocardiography (DSE) and myocar-
dial perfusion imaging are commonly used to detect viable
but dysfunctional myocardium. In studies that evaluated the
improvement of function on the segmental basis, SPECT and
PET demonstrate excellent sensitivity, whereas echocardiogra-
phy with dobutamine stress has superior speciﬁcity and posi-
tive predictive value.2
Tissue Doppler imaging (TDI) is evolving as a useful echo-
cardiographic tool for quantitative assessment of left ventricu-
lar (LV) systolic and diastolic function.3
Systolic tissue velocity imaging and post systolic shortening
during acute coronary occlusion were correlated to the recov-
ery of LV systolic function measured early and late after reper-
fusion. These results suggested that tissue velocity imaging
may be related to an active process reﬂecting myocardial
viability.4
Several studies demonstrated the potential role of tissue
Doppler imaging during dobutamine stress echocardiography
to quantify myocardial velocity and deformation, instead of
or in addition to traditional evaluation of the wall motion
score index (WMSI).5 However, its application during stress
echocardiography remains controversial since no clear advan-
tage in terms of both test interpretation and objective quanti-
ﬁcation has been demonstrated.6 Other studies concerning
TDI proved its diagnostic value for the detection of myocar-
dial viability during DSE and subsequent recovery after suc-
cessful revascularization.7
2. Aim of the work
The aim of the work was to clarify the value of dobutamine
stress tissue Doppler in the evaluation of LV functional
improvement after elective PCI.
3. Patients and methods
This study included 60 patients with IHD who were referred to
the Benha university hospital, Cardiology department for eval-
uation of viability prior to revascularization during the period
from March 2012 to March 2014.Exclusion criteria:
 Recent myocardial infarction or ACS.
 AF or any Ventricular arrhythmias.
 Previous pace maker implantation.
 Dilated cardiomyopathy.
 RHD.
 Prosthetic valve disease.
 Complicated PCI.
 LVEF less than 45%.
 Patients whose viability studies showed no signiﬁcant
viable myocardium or scar tissue.
Patients will undergo the following:
1) Detailed history – Age, sex, typical ischemic symptoms
and presence of risk factors (DM, HTN, smoking, dysl-
ipidemia and positive FH of IHD).
2) Thorough physical examination – for assessment of the
severity of IHD or HF symptoms (clinically S3 gallop,
mitral regurgemurmur or bilateral ﬁne basal crepitation).
3) Laboratory routine investigations – Complete blood
count, random blood sugar, liver function test, kidney
function test and coagulation proﬁle.
4) ECG.
5) Echocardiography.
3.1. The conventional echocardiography study
Patients were imaged in the left lateral decubitus position using a
commercially available system (Vivid 7, General Electric Ving-
med). Images were obtained with simultaneous ECG-signals.
3.1.1. 2D echo
Images were acquired during breath hold and saved in cine-loop
format, from the three 2 consecutive beats. The biplane Simp-
son’s technique was used to calculate LV end systolic volumes
(LVESVs), LV end diastolic volumes (LVEDVs) and LVEF.
3.1.2. M-mode echo
Measurement of LV dimensions in systole and diastole
(LVIDs, LVIDd), interventricular septum (IVSd, IVSs), pos-
terior wall thickening (PWTd) and LVEF% was carried out.
3.1.3. Pulsed wave Doppler echo
Pulsed-wave Doppler of the mitral valve was obtained by
placing the Doppler sample volume between the tips of the
Value of dobutamine stress tissue Doppler 263mitral leaﬂets. The early (E) and late (A) peak diastolic veloc-
ities and E-wave deceleration time were measured.
3.2. Dobutamine stress echocardiography
The patients abstain from all oral intake for at least 3 h before
the procedure. B-blockers were withheld 48 h before the test-
ing. Dobutamine was administered intravenously by an infu-
sion pump at a starting dose of 10 lg/kg/min. At least at
3 min intervals, the dosage was increased to 20 lg/kg/min.
Throughout the dobutamine infusion, the ECG was continu-
ously monitored and recorded at 1 min interval and blood
pressure was recorded every 3 min.8
End points of interruption of the test:
(1) Extensive new wall motion abnormalities.
(2) Severe angina.
(3) Symptomatic reduction in systolic blood pressure (SBP)
>40 mmHg from the baseline (See Fig. 1).
(4) Severe hypertension (BP > 240/120 mmHg).
(5) Signiﬁcant arrhythmias.
(6) Any serious side effects regarded as being due to
dobutamine infusion.
(7) Upon patient request.9
The echocardiographic images are digitized and displayed
side-by-side in quad screen format to facilitate the comparison
of images. Wall motion is evaluated visually, using both
endocardial motion and systolic wall thickening (See Fig. 2).Figure 1 Average pulsed wave TD (Sm) of the patient at baseline abo
(B) Pulsed TD (Sm) at the level of basal anterior about 8 cm/s, (C) Pul
TD (Sm) at the level of basal lateral about 8 cm/s.
Figure 2 Average pulsed wave TD (Sm) of the patient at dobutamin
septal about 20 cm/s, (B) Pulsed TD (Sm) at the level of basal anterio
about 15 cm/s, (D) pulsed TD (Sm) at the level of basal lateral about(a) According to the American Society of Echocardiogra-
phy, in a 16-segment model or optionally 17-segment
model with an addition of the apical cap, the following
numerical score is assigned to each wall segment on
the basis of its contractility as assessed visually.
(b) Wall motion score index (WMSI): The American Society
of Echocardiography has recommended a 16-segment
model. This model consists of six segments at both the
basal and mid-ventricular levels and four segments at
the apex. The attachment of the right ventricular wall to
the left ventricle deﬁnes the septum, which is divided at
basal and mid-left ventricular levels into antero-septum
and infero-septum. Continuing counterclockwise, the
remaining segments at both basal and mid-ventricular
levels are labeled as inferior, infero-lateral, antero-lateral
and anterior. The apex includes septal, inferior, lateral
and anterior segments. Each segment was analyzed and
scored on the basis of its motion and systolic thickening.
Segments were scored as normal (>40% thickening with
systole) = 1, hypokinesis (10–30% thickening) = 2,
akinesis (<10% thickening) = 3, dyskinesis = 4 and
aneurysmatic = 5. WMSI was derived as the sum of all
scores divided by the number of segments visualized.10
3.3. Tissue velocity imaging
By activating the DTI function in the echocardiographic
machine, the mitral annular velocities were recorded using theut 7 cm/s. (A) Pulsed TD (Sm) at the level of basal septum 6 cm/s,
sed TD (Sm) at the level of basal inferior about 6 cm/s, (D) Pulsed
e stress about 17.5 cm/s. (A) Pulsed TD (Sm) at the level of basal
r about 20 cm/s, (C) Pulsed TD (Sm) at the level of basal inferior
14 cm/s with observed improved values during the stress test.
264 S.A. Mostafa et al.pulsed-wave DTI. From the apical 4- and 2-chambers views,
the longitudinal mitral annular velocities were recorded from
septal, lateral, inferior and anterior LV sites. A mean value of
the above four sites were used. The velocities were taken into
account: the positive peak systolic velocities when the mitral
annulus moved toward the cardiac apex due to longitudinal
contraction of the LV. A mean of the three consecutive cycles
was used to calculate all echo-Doppler parameter (See Fig. 3).3
All echocardiographic parameters (LVEF, WMSI and TD
Sm), were detected twice (at rest and during dobutamine stress
after each stage). All patients underwent coronary revascular-
ization by elective PCI.
3.4. Angiographic procedure
Coronary angiography was performed via the femoral
approach, using the standard technique with 7Fr arterial
sheath. Non-infarct-related coronary was visualized ﬁrst, and
then IRA was visualized and treated. The goal of PCI was to
restore TIMI 3 grade ﬂow, assessed following standard crite-
ria: with residual stenosis <30% at visual estimation, which
was deﬁned as a successful procedure. Complete procedural
success was deﬁned as <30% residual stenosis and TIMI 3
ﬂow on every lesion treated, whereas partial success was
deﬁned as a residual stenosis >30% or TIMI <3 ﬂow on
non-IRA lesions. No-reﬂow phenomenon was deﬁned as TIMI
myocardial perfusion grade <3, assessed following standard
criteria, and reported. Complete revascularization was deﬁned
as absence of total occlusion and/or residual stenosis >70% inFigure 4 Wall Motion Score Index (WMSI), (A) at baseline, (B) at lo
observed improvement of the WMSI during the 3 different stages.
Figure 3 Average pulsed wave TD (Sm) of the patient at baseline, 1
basal septal about 8 cm/s, (B) Pulsed TD (Sm) at the level of basal anter
about 8 cm/s, (D) Pulsed TD (Sm) at the level of basal lateral abou
baseline values before the PCI.any major coronary artery or their major branches at
discharge (See Fig. 4).11
Follow up study:
One month later after doing elective PCI, a follow up rest-
ing conventional echocardiography and TDI were done for all
patients to detect the following parameters:
– Left ventricular function (LVEF) to determine the global
myocardial functional recovery.
– Wall motion score index (WMSI).
– Tissue velocity imaging (TD Sm).
Patients were considered to have global functional recovery
at the follow up stage if their LVEF% had improved by >5%
on 2-D follow up echocardiography as compared to LVEF%
at basal study before revascularization.12
Segmental recovery means the number of segments in each
patient that showed recovery of baseline wall motion
abnormalities.12
4. Results
4.1. Demographic characteristics of the studied patients
The study included 60 patients, 93.3% were male and 6.66%
were female with mean age 56.62 ± 2.59. As regards the risk
factors of the patients 30% of the patients were diabetics,
56.66% were hypertensive, 73.33% were smokers, 63.33%
were dyslipidemic and 10% had +ve FH of IHD.w dose dobutamine stress, (C) at 1 month follow up after PCI with
month follow up about 9 cm/s. (A) Pulsed TD (Sm) at the level of
ior about 10 cm/s, (C) Pulsed TD (Sm) at the level of basal inferior
t 10 cm/s with observed improved values in comparison with the
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them had previous anterior MI, 26.66% had previous infero-
lateral MI and 13.33% had previous NSEMI and UA.
63.33% of the patients were in Canadian class score (CCS) I,
23.33% were in class II and 13.335% were in class III.
83.33% of the patients were taking beta blockers (BB), 10%
were taking calcium channel blockers (CCB), 66.66% were
taking angiotensin converting enzyme inhibitors (ACEI) and
10% were taking nitrates. All patients were receiving aspirin
and statins.
As regards angiographic ﬁndings of patients during coro-
nary artery angiography, 65% of patients had single vessel dis-
ease (35% had LAD and 30% had LCX) and 35% of patients
had two vessel disease (both LAD and LCX).
PCI was done to LAD in 30 patients (50%), to LCX in 19
patients (31.66%) and to both LAD and LCX in 11 patients
(18.33%).
4.2. Response to dobutamine stress echo
As regards the hemodynamic response of the patients during
dobutamine stress test, there were high statistically signiﬁcant
differences in the values of SBP, DPB and HR during stress in
comparison with the rest of the values as the P-values were
0.001 (Table 1).
As regards the complication developed during the DSE,
16.66% of patients developed mild anginal pain, 23.33% of
them developed ECG-changes in the form of premature atrial
and ventricular contractions and 6.66% developed other com-
plications in the form of headache, dizziness and palpitation.
As regards the echocardiographic ﬁndings of the patients
including the EF, WMSI and TD average (Sm), there were sta-
tistically highly signiﬁcant differences between values at rest
and those during the low dose stress as the P-values were
0.001 (Table 1).
4.3. At 1 month follow up
After 1 month a follow up study was done and patients were
classiﬁed into two groups: 18 patients (30%) had non recov-
ered global myocardial function (Group I) and 42 patients
(70%) had recovered myocardial function both globally
(improved EF) and at segmental level (improved WMSI)
(Group II).
There were no statistically signiﬁcant differences between
the two groups as regards age and sex or risk factors as the
P-value was >0.05.
As regards the clinical presentation of the studied patients
according to the global functional recovery including theTable 1 Hemodynamic and echocardiographic variables of the stud
Variable Rest Low d
Range Mean ± SD Range
SBP 100–125 114.08 ± 9.59 120–15
DBP 65–85 73.08 ± 7.2 80–105
HR 65–105 86.78 ± 12.88 85–134
EF 47–55 51.17 ± 2.69 51–58
WMSI 1.36–1.7 1.52 ± 0.11 1.12–1
TD (Sm) 3.5–7 5.37 ± 0.98 9–21ACS type (STEMI, NSTEMI and UA), CCS and medical
treatment including beta blockers (BB), calcium channel
blockers (CCB), angiotensin converting enzyme inhibitors
(ACEI) and nitrate, there were no statistically signiﬁcant dif-
ferences between the two groups as the P-values were >0.05.
4.3.1. Hemodynamic response in Group I
As regards the hemodynamic response of the studied patients
during the dobutamine stress in non-recovered group (Group
I), the mean SBP was 112.78 ± 11.14 mmHg at rest and
138.33 ± 13.39 mmHg during the stress, the mean DBP was
73.06 ± 7.3 mmHg at rest and 93.06 ± 10.02 mmHg during
the stress and the mean HR was 85.67 ± 15.24 b/min at rest
and 115.72 ± 18.28 b/min during the stress with statistically
signiﬁcant differences in relation to the different stages of the
test as the P-values were highly signiﬁcant (0.001).
4.3.2. Hemodynamic response in Group II
As regards the hemodynamic response of the studied patients
during the dobutamine stress in recovered group(Group II),
the mean SBP was 114.64 ± 8.93 mmHg at rest and
144.29 ± 9.73 mmHg during the stress, the mean DBP was
73.1 ± 7.24 mmHg at rest and 96.9 ± 6.89 during the stress
and the mean HR was 87.26 ± 11.9 b/min at rest and
120.29 ± 13.49 b/min during the stress with statistically signif-
icant differences in relation to the different stages of the test as
the P-values were highly signiﬁcant (<0.001).
4.3.3. Comparison between the two groups as regards
hemodynamic response
From a comparison between the two groups as regards the
hemodynamic response of the studied patients during the
dobutamine stress including SBP, DBP and HR, there were
no statistically signiﬁcant differences as the P-values of those
parameters were >0.05. Also in a comparison between the
two groups as regards the rate/pressure product (Robinson
index) during the stress, there was no statistically signiﬁcant
difference (P-value > 0.05).
4.3.4. Echocardiographic variables in Group I
As regards echocardiographic variables of the studied patients
in non-recovered group (Group I), the mean value of the EF
was 52.17 ± 2.43 at rest, 55.06 ± 2.69 during the stress and
56.5 ± 1.43 at 1 month follow up and the mean value of
WMSI was 1.49 ± 0.12 at rest, 1.26 ± 0.13 during the stress
and 1.24 ± 0.14 at 1 month follow up while, the mean value
of Sm of TD was 5.06 ± 0.91 at rest, 11.97 ± 2.36 during
the stress and 5.67 ± 1.01 at 1 month follow up withied patients in relation to different stages of the test.
ose DSE Paired test P-value
Mean ± SD
5 142.5 ± 11.18 67.65 0.001
95.75 ± 8.07 47 0.001
118.92 ± 15.07 69.13 0.001
54.95 ± 2.52 34.66 0.001
.5 1.25 ± 0.099 49.41 0.001
14.81 ± 3.9 23.62 0.001
Table 2 Echocardiographic response during (DSE) of the studied patients in non recovered group (Group I).
Variable Range Mean Paired t test P-value
EF
Rest 49–55 52.17 ± 2.43 Stress-rest = 18.12 0.001
LDDSE 51–58 55.06 ± 2.69 Follow-rest = 6.98 0.001
Follow 51–58 56.5 ± 1.43 Follow-stress = 2.2 0.042
WMSI
Rest 1.36–1.7 1.49 ± 0.12 Stress-rest = 80.28 0.001
LDDSE 1.12–1.5 1.26 ± 0.13 Follow-rest = 34.12 0.001
Follow 1.0–1.5 1.24 ± 0.14 Follow-stress = 4.2 0.001
TD (Sm)
Rest 4–6.5 5.06 ± 0.91 Stress-rest = 18.64 0.001
LDDSE 15-Sep 11.97 ± 2.36 Follow-rest = 5.91 0.001
Follow 7-Apr 5.67 ± 1.01 Follow-stress = 17.43 0.001
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to the different stages of the test as the P-values were highly
signiﬁcant (0.001) in all variables, also as regards the difference
between stress and follow up EF, P-value was signiﬁcant
(< 0.05) (Table 2).
4.3.5. Echocardiographic variables in Group II
As regards echocardiographic variables of the studied patients
in the recovered group (Group II), the mean value of the EF
was 50.74 ± 2.72 at rest, 54.9 ± 2.48 during the stress and
56.62 ± 2.81 at 1 month follow up and the mean value of
WMSI was 1.54 ± 0.11 at rest, 1.25 ± 0.08 during the stress
and 1.21 ± 0.10 at 1 month follow up while, the mean value
of Sm of TD was 5.5 ± 0.99 at rest, 16.02 ± 3.82 during the
stress and 7.48 ± 0.92 at 1 month follow up with statistically
signiﬁcant difference of all variables in relation to different
stages of the test as the P-values were highly signiﬁcant
(0.001) (Table 3).
4.3.6. Comparison between the two groups as regards
echocardiographic variables
From a comparison between the two groups as regards echo-
cardiographic variables of the studied patients in relation to
different stages of the test, there were no signiﬁcant differences
as regards the EF and WMSI, while, there was a statistically
signiﬁcant difference as regards the Sm parameter of the TDTable 3 Echocardiographic response during (DSE) of the studied p
Variable Range Mean
EF
Rest 47–54 50.74 ± 2.72
LDDSE 51–58 54.9 ± 2.48
Follow 52–60 56.62 ± 2.81
WMSI
Rest 1.42–1.7 1.54 ± 0.11
LDDSE 1.16–1.5 1.25 ± 0.08
Follow 1.0–1.5 1.21 ± 0.10
TD (Sm)
Rest 3.5–7 5.5 ± 0.99
LDDSE 11–21 16.02 ± 3.82
Follow 5.5–9 7.48 ± 0.92between the studied patients of both groups during the stress
and 1 month follow up as the P-value was highly signiﬁcant
(0.001) (Table 4).
4.3.7. Comparison between the two groups as regards
angiographic ﬁndings
Patients with single vessel disease showed a high signiﬁcant
incidence of the functional global recovery while, patients with
two vessel disease showed a signiﬁcant incidence of the non-
global functional recovery.
4.3.8. Regression analysis showing the predictors of the recovery
From a comparison between the two groups as regards risk fac-
tors, a multivariate regression analysis of echocardiographic
data shows no signiﬁcant difference between the two groups
regarding those parameters while a univariate regression analysis
shows that the TD (Sm) parameter is the only predictor for the
global functional recovery.
4.3.9. ROC curve for identiﬁcation of cut-off value and accuracy
of low dose dobutamine stress WMSI for prediction of functional
recovery
By demonstration of the values derived from ROC curve for
the identiﬁcation of cut-off value and accuracy of WMSI
parameter during low dose dobutamine stress for the predic-
tion of functional recovery, the cut-off value was 1.35 whichatients in non recovered group (Group II).
Paired t test P-value
Stress-rest = 46.49 0.001
Follow-rest = 75.66 0.001
Follow-stress = 17.47 0.001
Stress-rest = 52.87 0.001
Follow-rest = 52.48 0.001
Follow-stress = 8.2 0.001
Stress-rest = 23.03 0.001
Follow-rest = 32.22 0.001
Follow-stress = 18.47 0.001
Table 4 Comparison between two groups as regards echocardiographic variables of the studied patients in relation to different stages
of the test.
Variable Non-recovered patients N= 18(30%) Recovered patients N= 42(70%) St t test P-value
EF
* Rest 52.17 ± 2.43 50.74 ± 2.72 1.93 0.059 NS
* LDDSE 55.06 ± 2.69 54.9 ± 2.48 0.211 0.834 NS
* Follow up 56.5 ± 1.43 56.62 ± 2.81 0.17 0.866 NS
WMSI
* Rest 1.49 ± 0.12 1.54 ± 0.11 1.6 0.116 NS
* LDDSE 1.26 ± 0.13 1.25 ± 0.08 0.503 0.617 NS
* Follow up 1.24 ± 0.14 1.21 ± 0.10 0.828 0.411 NS
TD (Sm)
* Rest 5.06 ± 0.91 5.5 ± 0.99 1.63 0.109 NS
* LDDSE 11.97 ± 2.36 16.02 ± 3.82 4.16 0.001 HS
* Follow up 5.67 ± 1.01 7.48 ± 0.92 6.75 0.001 HS
Value of dobutamine stress tissue Doppler 267gave a sensitivity of 50%, speciﬁcity of 97%, PPV of 90%,
NPV of 82% and accuracy of 83%. The area under the curve
(AUC) was 0.493.
4.3.10. ROC curve for identiﬁcation of cut-off value and
accuracy of dobutamine stress TD (Sm) parameter for
prediction of functional recovery
By demonstration of the values derived from ROC curve for
the identiﬁcation of cut-off value and accuracy of TD (Sm)
parameter during dobutamine stress for the prediction of func-
tional recovery, the cut-off value was 16 which gave a sensitiv-
ity of 100%, speciﬁcity of 74.6%, PPV of 55%, NPV of 100%
and accuracy of 93.3%. The area under the curve (AUC) was
0.735 with an observed larger area under the curve (AUC)
which indicates better sensitivity and accuracy of TD Sm
parameter compared with the WMSI of DSE for the predic-
tion of functional recovery of the viable myocardium after
doing revascularization.5. Discussion
The differentiation of viable from non-viable myocardium is
highly relevant in patients who are being considered for revas-
cularization. Dysfunctional but viable myocardium can still
preserve a contractile reserve, which may be evoked by an
appropriate stimulus.13
In patients with jeopardized but viable myocardium, the
LV ejection fraction (EF) will show improvement with low-
dose dobutamine in direct proportion to the number of seg-
ments with contractile reserve.8
Prediction of functional recovery, based on the detection of
contractile reserve with dobutamine stress echocardiography
(DSE), includes myocardial perfusion imaging, metabolic
imaging with conventional scintigraphy and positron emission
tomography (PET).12
Dobutamine stress echocardiography is widely used in the
clinical setting because it is a safe and accurate method for
the detection of myocardial viability. The main limitation of
dobutamine echocardiography is its subjective interpretation.8
Several studies demonstrated the potential role of tissue
Doppler imaging during dobutamine stress echocardiography
to quantify myocardial velocity and deformation, instead of
or in addition to traditional evaluation of the wall motionscore index (WMSI).14,5 However, its application during stress
echocardiography remains controversial since no clear advan-
tage both in terms of test interpretation or objective quantiﬁ-
cation has been demonstrated.6
Identiﬁcation of small changes in myocardial wall velocities
during dobutamine challenge has been shown to be feasible
with TDI. Hence, TDI is a quantitative technique for the
assessment of myocardial velocities and is at least as accurate
in identifying viable myocardium in patients with CAD and
myocardial dysfunction as other traditional qualitative
method.15 Previous investigators have shown that systolic
velocity changes during dobutamine infusion are seen as sensi-
tive indexes of myocardial viability.16
The present study was concluded on sixty patients with IHD
and hibernating viable myocardium proved by DSE who were
referred for evaluation of myocardial viability prior to revascu-
larization, then they were followed up 1 month later after doing
elective PCI to detect functional myocardial recovery.
Every patient was subjected to careful history taking, full
clinical examination, resting standard 12-leads ECG, full 2D,
M-mode, Doppler echocardiography in the standard views,
dobutamine stress and tissue Doppler velocities. All parame-
ters including the hemodynamic data and echocardiographic
variables (LVEF, WMSI and TD Sm) were assessed twice, at
rest and during dobutamine stress.
All patients underwent coronary revascularization (elective
PCI) after assessment by DSE and TDI. Follow up 2-D conven-
tional echocardiography and TDI were done one month after
coronary revascularization and all echocardiographic variables
were assessed again at rest. Global functional recovery was
identiﬁed if the EF had improved by more than 5% on the fol-
low up study.
In the present study, patients were classiﬁed according to
the global functional recovery at 1 month follow up into two
groups:
Group I: included 18 patients (30%) with no global func-
tional recovery.
Group II: included 42 patients (70%) with global functional
recovery.
The mean age of our patients was 56.62 ± 2.59. 56 patients
(93.33%) were male and 4 patients (6.66%) were female. As
regards their risk factors, 18 patients (30%) were diabetic, 34
268 S.A. Mostafa et al.patients (56.66%) were hypertensive, 44 patients (73.33%)
were smokers, 38 patients (63.33%) were dyslipidemic and 6
patients (10%) had previous +ve FH of IHD. As regards
the clinical presentations of the patients, 36 patients (60%)
had previous anterior and anterolateral MI, 16 patients
(26.66%) had previous inferolateral MI and 8 patients
(13.33%) had previous NSTEMI and UA. As regards the med-
ications, all patients were receiving aspirin and statins, 50
patients (83.33%) were taking BB, 6 patients (10%) were tak-
ing CCB and 40 patients (66.66%) were taking ACEI. Angio-
graphic ﬁndings of our patients showed 39 patients (65%) had
single vessel disease (35% was LAD and 30% was LCX) and
21 patients (35%) had two vessel disease. On comparison
between the two groups, there were no statistically signiﬁcant
differences as regards the demographic data, risk factors and
clinical presentation.
On another similar study, 42 patients with previous myo-
cardial infarction with documented signiﬁcant coronary artery
disease by coronary angiography were submitted for elective
coronary revascularization of the infracted related artery.
The mean age of the patients was 53.5 ± 8.7, 38 patients
(90.5%) were male, 4 patients (9.5%) were female. As regards
risk factors, 15 patients (35.7%) were diabetic, 16 patients
(38%) were hypertensive, 15 patients (35.7%) were dyslipidem-
ic and 9 patients (21.4%) had +ve FH of IHD. Regarding
clinical presentation, 24 patients (57.1%) had previous anterior
MI , 5 patients (11.9%) had previous inferior and lateral MI,
13 patients (31%) had previous anterior and inferior MI. As
regards angiographic ﬁndings, 9 patients (21.4%) had single
vessel disease, 13 patients (31%) had 2 vessel disease and 20
patients (47.6%) had 3 vessel disease.17
Also, in another study, 73 consecutive patients presented
with previous anterior myocardial infarction, underwent some
form of coronary revascularization for the signiﬁcant coronary
stenosis. The mean age of those patients was 49.8 ± 10.3, 62
patients (84.9%) were male, 11 patients (15%) were female,
45 patients (61.6%) were smoker, 38 patients (52.1%) were
hypertensive, 37 patients (50.5%) were diabetic, 43 (58.9%)
were dyslipidemic. As regards medical treatment patients
received, 48 patients (65.8%) were on BB, 54 patients (73.9%)
were on ACEI and 23 patients (31.5%) were on CCB.18
Since the functional recovery is the gold standard of myo-
cardial viability assessment, the present study used the myocar-
dial viability to detect the global functional recovery after
revascularization.
The identiﬁcation of contractile reserve during DSE has
been shown to provide important prognostic information
and clinical outcome. Contractile reserve is deﬁned as the dif-
ference between values of an index of LV contractility during
stress and its baseline values. Ejection fraction (EF) and wall
motion score index (WMSI) are the most frequently used indi-
ces of LV performance.12
Interestingly, from our study’s major ﬁndings, an increase
in the ejection velocities of the myocardium was observed dur-
ing the test in all patients. Also improvement of both global
myocardial function (LVEF) and WMSI parameters was
observed. The increase in ejection velocities during dobuta-
mine stress test seems to be an reliable index for accurate iden-
tiﬁcation of myocardial viability in patients with ischemic
heart disease and subsequent myocardial recovery after
coronary revascularization.In agreement with the present study Gorcson et al., who
demonstrated increased sensitivity of myocardial viability
detection by using pulsed wave Doppler tissue samplings com-
pared to dobutamine stress echocardiography.19
Also, Hoffmann et al. had validated the TDI technique as a
clinical tool and that study correlated the dobutamine response
with metabolic evidence of viability by PET. Thirty-seven
patients with ischemic heart disease who underwent low-dose
dobutamine stress echocardiography and positron emission
tomography were studied. Viability was deﬁned on the basis
of perfusion metabolism mismatch and tissue velocity imaging
was found to be more accurate than dobutamine in the predic-
tion of viability.20
Also Penicka et al. tested the ability of peak systolic veloc-
ities to predict recovery of myocardial function after coronary
revascularization. They showed that a positive systolic velocity
after revascularization predicts recovery of function in the rep-
erfused area. This suggests that the measurement of systolic
velocities may provide important diagnostic information with
regard to myocardial viability and subsequent recovery after
coronary revascularization.21
Similarly, Manish et al. compared myocardial tissue velocity
imaging and speckle tracking echocardiography (STE) for the
prediction of myocardial viability at dobutamine stress echo-
cardiography. Fifty-ﬁve patients with ischemic heart disease
underwent DSE for evaluation of myocardial viability. Func-
tional recovery was deﬁned by improved wall motion-score
on side-by-side comparison of echocardiography images before
and after revascularization. Only TD parameter predicted the
functional recovery independent of wall motion analysis.22
In the present study, echocardiographic variables of EF,
WMSI and average (Sm) parameter of TDI at rest, dobuta-
mine stress and one month follow up resting values were
assessed. For each parameter assessed, values in different
groups were related to different stages of the test; they were
related to global functional recovery. All the studied parame-
ters showed statistically signiﬁcant differences as regards stages
of the test and at follow up study. There were statistically sig-
niﬁcant differences as regards the Sm parameter of TD values
in relation to global functional recovery and this can be
explained by improvement in contractility and related to path-
ological changes if the amount of viable myocytes in relation
to ﬁbrotic tissue is too high and also, improved the integrity
of cardiac myocyte cell membranes after revascularization.
However, as regards global functional recovery, EF & WMSI
were not statistically signiﬁcantly different and these can be
explained by a delayed improvement in the myocardial relaxa-
tion and a varying lag in contractile recovery after revascular-
ization as in most studies, follow up improvements in those
parameters were observed between 6 and 9 months.
In agreement with our ﬁndings, Auerbach et al. found no
signiﬁcant difference as regards LVEF between patients with
contractile recovery and those without myocardial recovery
after revascularization.23
In disagreement with that, Leclercq et al. proved that there
is a better signiﬁcant correlation between the left ventricular
function and contractile recovery in comparison with non-
recovery after revascularization. And these controversies can
be explained by different heterogeneous nature of the underly-
ing disease process and lack of uniformity in patient selection
and study protocols among different studies.24
Value of dobutamine stress tissue Doppler 269In agreement also with our study ﬁndings, there were sev-
eral studies that tested the accuracy of TD parameter for the
prediction of functional recovery after revascularization, as
well discussed in the following:
Katz et al. assessed the accuracy of TD and concluded that
peak ejection velocities of the dysfunctional viable myocar-
dium predict recovery after reperfusion.25
Also, Yamada et al. assessed the value of TD during DSE
in the detection of contractile reserve and demonstrated that
higher Sm velocity of TD was associated with improved global
LV function after revascularization.26
In agreement with this study, another additional study
reported that systolic mitral annular motion toward the cardiac
apex measured with echocardiography could have a high
degree of sensitivity and speciﬁcity for the detection of myocar-
dial viability. It was found that a correlation between ejection
fraction and the systolic mitral annular velocity is relatively
good irrespective of the presence or absence of mitral regurge.27
Also, Penicka et al., used low-dose dobutamine TD param-
eters (peak systolic velocities and pre-ejection velocities) to
predict myocardial functional recovery after revascularization
and found those parameters more speciﬁc and accurate com-
pared with WMSI detected with DS.21
Also from our ﬁnding, ROC curve statistical analysis shows
that TD Sm is more sensitive and accurate than WMSI in the
detection of viable myocardium which predicts improvement
after revascularization (sensitivity 100%, 50% and accuracy
93.3%, 83.3% respectively).
In agreement with our study, Celutkiene et al. reported that
the peak systolic velocity during DSE was the most accurate
index of prediction of contractile reserve (sensitivity 73–100%,
speciﬁcity 82–97%).28
Also, Antonio et al. assessed quantitative segmental analy-
sis by TDI technique during DSE for detecting myocardial
recovery after revascularization in patients with IHD and seg-
mental myocardial dysfunction and compared results with
those of 2D echocardiography and tissue Doppler imaging
(TDI) as well as rest – 4–24 h redistribution thallium SPECT.
Forty-one patients underwent dobutamine 2D/TDI and
SPECT before and after revascularization. Sensitivity, speciﬁc-
ity and accuracy of regional myocardial recovery were 73%,
81% and 77% for dobutamine 2D and 77%, 82% and 80%
for dobutamine TDI.29
In another report, Aggelic et al. investigated low dose
dobutamine stress echocardiography combined with tissue
Doppler imaging for the assessment of myocardial recovery
after revascularization. Conventional qualitative LDDSE
showed sensitivity of 78%, speciﬁcity of 85% for prediction
of recovery.30
Also, Enbiya et al. concluded that strain/strain rate imaging
was better for myocardial deformation changes following PCI
and for assessment of viability than tissue Doppler velocity
imaging (TDI). SR > strain > TDI (P-value = 0.004, 0.012
and 0.099 respectively).31
Also from our observed ﬁndings as regards the angio-
graphic data, from a comparison between the two groups,
patients with single vessel disease (39 patients 65%) showed
a highly signiﬁcant incidence of recovery while, patients with
two vessel disease (21 patients 35%) showed a signiﬁcant inci-
dence of the non-functional recovery. This can be explained by
the extensive presence of microvascular obstruction in patients
with multivessel disease which affects the success of thereperfusion process and subsequent myocardial remolding that
impacts recovery.
In agreement with those ﬁndings, Paul et al. concluded that
patients with extensive CAD remote from the infracted related
artery have reduced reperfusion success, myocardial recovery
and associated adverse clinical outcome.32
Also, Stein et al. reported that patients with multivessel dis-
ease showed delayed recovery and adverse outcomes in com-
parison with those with single vessel.33
From the previously mentioned results, it has been sug-
gested that TDI provides a feasible and quantitative technique
that improves reproducibility of dobutamine stress echocardi-
ography. Peak systolic velocity (PSV) of TDI with low-dose
dobutamine showed better accuracy than visual assessment
of WMSI during DSE for the prediction of functional recovery
following revascularization. However, that needs to be con-
ﬁrmed in studies with larger patient population.6. Conclusion
From the previously mentioned results, it has been suggested
that stress TDI provides a feasible and quantitative technique
that improves reproducibility of dobutamine stress echocardi-
ography. Systolic tissue velocity imaging (Sm) during dobuta-
mine stress showed better accuracy than visual assessment of
WMSI for the prediction of functional recovery following
revascularization.
Among the different TDI parameters, systolic velocity (Sm)
was a simple, sensitive and accurate parameter for that pur-
pose even in the detection of subtle myocardial systolic velocity
changes.Conﬂict of interest
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